AzTrials
AzTrials

Obstructive Sleep Apnea Risk ManagementNCT06430957

OSA Risk Level in Dental Patients and Correlation With Complications After General Anesthesia

An observational study of Obstructive Sleep Apnea Risk Management and Postoperative Complications, run by Kırıkkale University at 2 sites in Turkey (Türkiye).

Recruiting

Looking for participants now. Contact the study team or a site below to ask about taking part.

Sites and contacts
Official record
Search all trials

Trial summary

Obstructive sleep apnea (OSA) is a sleep-related respiratory dysfunction. The prevalence of OSA is increasing with the increasing rates of obesity and elderly population worldwide. Perioperative anesthesia management should be adjusted to improve patient safety in patients with OSA. Read more about this study

Who is it for?
Ages 18 to 80 years
What is being tested?
The STOP-BANG questionnaire for determining OSA risk level., ASA recommended criteria for determining OSA risk level. and Record of postoperative complications
How many people
240 participants
Where
2 sitesTurkey (Türkiye)
Study dates
28 Jun 2024to Aug 2026
Phase
Observational
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 80 years
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Study population: Patients between the ages of 18-80 years who applied to the anesthesia clinic for dental procedures planned to be performed under general anesthesia and who had no previous diagnosis of OSA.

Who may be able to join

  • Patients between 18-80 years of age who apply to the anesthesia clinic for dental procedures planned to be performed under general anesthesia
  • Patients without a previous diagnosis of OSA

Who cannot join

  • Individuals who do not want to participate in the study
  • Patients previously diagnosed with OSA
  • Necessity of emergency surgery

Trial locations and contacts

2 sites in 1 country. Contact the study team or a site near you to ask about taking part.

Gözde Nur Erkan, Asst. Prof. contact

+905054334692

dr.gozdenur@gmail.com

Turkey (Türkiye)2 sites, 2 recruiting
  • Erciyes University Faculty of Dentistry

    Kayseri

    Dilek Günay Canpolat, dgcanpolat@gmail.com

    Recruiting
  • Kırıkkale University Faculty of Dentistry

    Kirikkale

    Gözde Nur Erkan, +903182244927 ext. 7140, dr.gozdenur@gmail.com

    Recruiting

Other trials in Turkey (Türkiye)

About this study

Official title: Evaluation of OSA Risk Levels in the Preoperative Period of Adult Patients With Planned Dental Procedures Under Anesthesia and Correlation With Postoperative Complications; A Multicenter Study

Obstructive sleep apnea (OSA) is a sleep-related respiratory dysfunction. The prevalence of OSA is increasing with the increasing rates of obesity and elderly population worldwide. Perioperative anesthesia management should be adjusted to improve patient safety in patients with OSA. In OSA patients, positive pressure ventilation support may be required in the preoperative period, various ventilation strategies may be required in the intraoperative period, different pharmacologic agents may need to be avoided, and intensive care unit follow-up or noninvasive ventilation support may be required in the postoperative period. However, it is reported that a significant percentage of OSA patients remain undiagnosed. ASA (American Society of Anesthesiologists) has reported the criteria that should be questioned in order to determine the risk of patients in terms of OSA and to initiate the diagnostic process in risky patients and to make appropriate anesthesiologic arrangements in the perioperative period. In addition, the STOP-BANG assessment scale, which is widely used all over the world in OSA risk assessment, is also used in OSA risk assessment. It is thought that dental caries and extraction needs may be higher in OSA patients, especially since open-mouth sleeping accompanies the situation. In this respect, it is also important for patients to be diagnosed with OSA as it may prevent dental damage due to open-mouth sleeping in the future. Identifying patients at risk for OSA and directing them to the diagnostic process is very important for patient safety. Within the scope of the study, the criteria recommended by ASA and STOP-BANG score will be evaluated and recorded. Risk stratification in terms of STOP-BANG questionnaire and ASA criteria will be done separately for each patient and for each classification method. Patients at high risk will be consulted to the relevant medical department in the preoperative period for further investigation and treatment. In addition, it is aimed to correlate the risk levels determined in the study with postoperative respiratory complications and recovery time.

Being tested
The STOP-BANG questionnaire for determining OSA risk level., ASA recommended criteria for determining OSA risk level., Record of postoperative complications
Medical subject headings
Postoperative Complications

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • The STOP-BANG questionnaire for determining OSA risk level.Other

    An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.

  • ASA recommended criteria for determining OSA risk level.Other

    An assessment questionnaire including OSA-related physical characteristics and symptoms and signs to be questioned individually in each patient will be examined by the physician.

  • Record of postoperative complicationsOther

    Respiratory complications as laryngospasm/bronchospasm, apnea, hypoxia, duration and amount of need for additional oxygen support and recovery time (duration of modified aldrete score of 9 and above) will be recorded.

Study groups in NCT06430957
Study groupRoleWhat they receive
Group lowSTOP-BStudy group including patients in the low-risk group in the assessment to be made with STOP-BANG questionnaire.
Receives: Other: The STOP-BANG questionnaire for determining OSA risk level.; Other: Record of postoperative complications
Group intermediateSTOP-BStudy group including patients in the medium-risk group in the assessment to be made with STOP-BANG questionnaire.
Receives: Other: The STOP-BANG questionnaire for determining OSA risk level.; Other: Record of postoperative complications
Group highSTOP-BStudy group including patients in the high-risk group in the assessment to be made with STOP-BANG questionnaire.
Receives: Other: The STOP-BANG questionnaire for determining OSA risk level.; Other: Record of postoperative complications
Group noneASAThe study group that includes patients who are not at risk for OSA in the evaluation with the criteria recommended by the ASA.
Receives: Other: ASA recommended criteria for determining OSA risk level.; Other: Record of postoperative complications
Group mildASAStudy group including patients in the mild-risk group for OSA in the evaluation with the criteria recommended by the ASA.
Receives: Other: ASA recommended criteria for determining OSA risk level.; Other: Record of postoperative complications
Group moderateASAStudy group including patients in the moderate-risk group for OSA in the evaluation with the criteria recommended by the ASA.
Receives: Other: ASA recommended criteria for determining OSA risk level.; Other: Record of postoperative complications
Group severeASAStudy group including patients in the severe-risk group for OSA in the evaluation with the criteria recommended by the ASA.
Receives: Other: ASA recommended criteria for determining OSA risk level.; Other: Record of postoperative complications

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Determination of OSA risk levels of patients

    The STOP-BANG questionnaire and the criteria recommended by the ASA, which are recommended to be used routinely worldwide to determine OSA risk level, will be questioned in each patient. Patients with moderate and high risk scores from the STOP-BANG questionnaire and patients with significant OSA risk level according to ASA criteria will be referred to the pulmonology department and further evaluation will be requested. If deemed necessary by the Pulmonology department, a sleep test will be performed. With the sleep test result, the OSA risk level of the patients will be classified as none, mild, moderate and severe in terms of ASA criteria.

    Measured: Preoperative period

  2. Postoperative respiratory complications

    Respiratory complications including laryngospasm/bronchospasm, apnea, hypoxia that may develop in the postoperative period in patients, the duration of the need for additional oxygen support above the expected duration will be observed and recorded.

    Measured: For 4 hours after the end of surgery

  3. Follow-up of indicators of airway obstruction

    As indicators of airway obstruction; snoring/whistling respiration, hypertension and intercostal/sternal retractions will be observed and recorded in the study follow-up form.

    Measured: For 4 hours after the end of surgery

  4. Duration of recovery

    Duration of recovery (modified aldrete score of 9 and above) will be recorded

    Measured: For 30 minutes after the end of surgery

Secondary outcomes (1)
  1. Comparison of the effectiveness of STOP-BANG questionnaire and ASA criteria in determining OSA risk level

    Patients who will receive an intermediate or high risk score from either of the two assessment questionnaires will be referred for further evaluation and diagnosis of suspected OSA. At the end of the diagnostic process, it is planned to investigate which of the two scoring systems more successfully identifies patients with OSA and assigns a higher risk.

    Measured: Perioperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 May 2024
  2. Study start28 Jun 2024
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
240 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06430957
Sponsor's protocol ID
KU-ERKAN-002
Status last verified
Aug 2025
First submitted
14 May 2024
Last updated
20 Mar 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Questions about this trial

What is this clinical trial studying?

An observational study of Obstructive Sleep Apnea Risk Management and Postoperative Complications, run by Kırıkkale University at 2 sites in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: looking for participants now, as of the sponsor's last update on 20 Mar 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 2 sites in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Gözde Nur Erkan, Asst. Prof. (+905054334692, dr.gozdenur@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Determination of OSA risk levels of patients (time frame: Preoperative period). The study lists 4 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Mar 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in